New Stock News | Haina Pharmaceutical submitted an application to the Hong Kong Stock Exchange, with business covering the entire chain of drug discovery, CMC, preclinical and clinical development, etc.

According to the 36Kr Financial APP, it was revealed by the Hong Kong Stock Exchange on November 7 that Nanjing Hanach Medicine Technology Co., Ltd. (Hanach Medicine) has submitted its listing application to the main board of the Hong Kong Stock Exchange, with China International Capital Corporation Limited (CICC) as its exclusive sponsor.